Both in Pharmaceuticals
Rigel Pharmaceuticals Inc. (New) vs Savara
Over the past year RIGL returned +67.8% and SVRA returned +7.7%; their daily moves had a correlation of 0.24.
RIGL +67.8% SVRA +7.7%Growth of $1, one year, split-adjusted
| Metric | RIGL | SVRA |
|---|---|---|
| Price | $51.44 | $4.60 |
| Market cap | $960.8M | $945.2M |
| Today | +5.27% | −3.15% |
| 1 month | +11.5% | −1.1% |
| 6 months | +92.9% | −12.7% |
| Year to date | +20.1% | −23.7% |
| 1 year | +67.8% | +7.7% |
| Revenue growth (YoY) | −22.6% | — |
| Gross margin | 89.2% | — |
| Net margin | 22.0% | — |
| P/E (TTM) | 3.0× | — |
| Price / sales | 3.5× | — |
| Net cash | $56.1M | $142.9M |
| Dividend yield | — | — |
| Volatility (60d) | 37.9% | 48.6% |
| Short % of float | 16.3% | 20.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).